Trial Profile
The effect of ranolazine on echocardiographic indices of diastolic dysfunction
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2019
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Diastolic heart failure
- Focus Therapeutic Use
- 31 Jul 2019 Status changed from recruiting to discontinued.
- 08 Jan 2008 New trial record.